193 related articles for article (PubMed ID: 8013429)
1. Cell proliferation and apoptosis in normal liver and preneoplastic foci.
Schulte-Hermann R; Bursch W; Kraupp-Grasl B; Oberhammer F; Wagner A; Jirtle R
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):87-90. PubMed ID: 8013429
[TBL] [Abstract][Full Text] [Related]
2. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression.
Grasl-Kraupp B; Ruttkay-Nedecky B; Müllauer L; Taper H; Huber W; Bursch W; Schulte-Hermann R
Hepatology; 1997 Apr; 25(4):906-12. PubMed ID: 9096596
[TBL] [Abstract][Full Text] [Related]
3. The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver.
Schulte-Hermann R; Schuppler J; Timmermann-Trosiener I; Ohde G; Bursch W; Berger H
Environ Health Perspect; 1983 Apr; 50():185-94. PubMed ID: 6873013
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1-induced cell death in preneoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen.
Müllauer L; Grasl-Kraupp B; Bursch W; Schulte-Hermann R
Hepatology; 1996 Apr; 23(4):840-7. PubMed ID: 8666340
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis in the liver and its role in hepatocarcinogenesis.
Schulte-Hermann R; Bursch W; Löw-Baselli A; Wagner A; Grasl-Kraupp B
Cell Biol Toxicol; 1997 Jul; 13(4-5):339-48. PubMed ID: 9298254
[TBL] [Abstract][Full Text] [Related]
6. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
[TBL] [Abstract][Full Text] [Related]
7. [Relevance of apoptosis for carcinogenesis].
Schulte-Hermann R; Bursch W; Grasl-Kraupp B
Verh Dtsch Ges Pathol; 1994; 78():15-21. PubMed ID: 7533977
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppression effects of bilberry extracts and enzymatically modified isoquercitrin in early preneoplastic liver cell lesions induced by piperonyl butoxide promotion in a two-stage rat hepatocarcinogenesis model.
Hara S; Morita R; Ogawa T; Segawa R; Takimoto N; Suzuki K; Hamadate N; Hayashi SM; Odachi A; Ogiwara I; Shibusawa S; Yoshida T; Shibutani M
Exp Toxicol Pathol; 2014 Aug; 66(5-6):225-34. PubMed ID: 24680176
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R
Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
[TBL] [Abstract][Full Text] [Related]
10. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
[TBL] [Abstract][Full Text] [Related]
11. Role of transforming growth factor alpha and prostaglandins in preferential growth of preneoplastic rat hepatocytes.
Hufnagl K; Parzefall W; Marian B; Käfer M; Bukowska K; Schulte-Hermann R; Grasl-Kraupp B
Carcinogenesis; 2001 Aug; 22(8):1247-56. PubMed ID: 11470756
[TBL] [Abstract][Full Text] [Related]
12. Initiated rat hepatocytes in primary culture: a novel tool to study alterations in growth control during the first stage of carcinogenesis.
Löw-Baselli A; Hufnagl K; Parzefall W; Schulte-Hermann R; Grasl-Kraupp B
Carcinogenesis; 2000 Jan; 21(1):79-86. PubMed ID: 10607737
[TBL] [Abstract][Full Text] [Related]
13. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B
IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
[TBL] [Abstract][Full Text] [Related]
15. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study.
Columbano A; Ledda-Columbano GM; Rao PM; Rajalakshmi S; Sarma DS
Am J Pathol; 1984 Sep; 116(3):441-6. PubMed ID: 6476080
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor (TGF)-beta1 and TGF-beta type II receptor in preneoplastic lesions during chemical hepatocarcinogenesis of rats.
Park DY; Hwang SY; Suh KS
Toxicol Pathol; 2001; 29(5):541-9. PubMed ID: 11695571
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of changes in cell proliferation and apoptosis during preneoplastic and neoplastic stages of hepatocarcinogenesis in rat.
Kong J; Ringer DP
Cancer Lett; 1996 Aug; 105(2):241-8. PubMed ID: 8697450
[TBL] [Abstract][Full Text] [Related]
19. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.
Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC
Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-beta.
Wollenberg GK; Semple E; Quinn BA; Hayes MA
Cancer Res; 1987 Dec; 47(24 Pt 1):6595-9. PubMed ID: 3499977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
